Don't forget to register for today's CLL webinar.
"How are advances in Bruton’s tyrosine kinase targeted therapies continuing to change how chronic lymphocytic leukemia (CLL) is treated?"
CLL Ireland patient advocate Jan Rynne will share her experience living with CLL for 11 years and now on a BTK inhibitor for more than eight years.
Great clinical speakers also.
Registration link below.
UK Webinar - Corona-virus and CLL - video now available 
